
Weight Loss Medications Linked to Severe Gastrointestinal Issues
Ozempic has been hailed as a breakthrough for weight loss and diabetes management. An estimated 1 in 8 Americans have taken GLP-1 drugs. But behind the success lies a disturbing reality. Patients are coming forward with claims of severe gastrointestinal complications, including stomach paralysis and life-threatening intestinal obstructions. Lawsuits filed nationwide accuse weight loss drug manufacturers Novo Nordisk and Eli Lilly and Company of failing to warn consumers about these risks, causing many patients to suffer in silence.
